Research Solutions (NASDAQ:RSSS – Get Free Report) issued its quarterly earnings results on Wednesday. The company reported $0.02 EPS for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.02), FiscalAI reports. The business had revenue of $12.08 million for the quarter, compared to the consensus estimate of $11.95 million. Research Solutions had a net margin of 5.84% and a return on equity of 16.32%.
Here are the key takeaways from Research Solutions’ conference call:
- Platform and recurring revenue continued to grow: Fiscal 2026 B2B ARR increased 14.1% to approximately $16.2 million, while total ARR rose 7.8% to $22.5 million. The higher-margin platform mix reached more than 43% of revenue, lifting full-year gross margin to 51.9%.
- AI products gained early commercial traction. AI-related ARR reached approximately $800,000 in the fourth quarter, with roughly $800,000 in AI bookings during the quarter and a pipeline that management said is now well above $1 million. MCP offerings have primarily driven upsells, with management reporting that adding agentic access roughly doubled average contract value.
- Legacy transaction revenue and B2C remain pressured. Fiscal 2026 transaction revenue declined 8.7%, and management expects another low-single-digit decline in fiscal 2027; B2C is also expected to be roughly flat amid competition and cost-sensitive customers.
- Management expects further profitability and cash-flow improvement. Fiscal 2026 net income rose to $2.8 million and adjusted EBITDA increased to $5.8 million, while the company ended the year with $12.6 million of cash, no debt, and flexibility for remaining Scite earn-out payments, acquisitions, or potential share repurchases.
Research Solutions Stock Performance
Shares of RSSS stock opened at $2.13 on Friday. The company has a market capitalization of $71.25 million, a P/E ratio of 23.67 and a beta of 0.75. Research Solutions has a fifty-two week low of $2.00 and a fifty-two week high of $4.12. The stock has a 50 day moving average price of $2.23 and a two-hundred day moving average price of $2.31.
Key Research Solutions News
- Positive Sentiment: Research Solutions reported record fiscal-year net income of $2.8 million, a 14% year-over-year increase in B2B annual recurring revenue, and total ARR of $22.5 million. These results support the company’s longer-term growth and profitability strategy. Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results
- Positive Sentiment: Management highlighted record gross margins and expects improved EBITDA and cash flow in fiscal 2027, which could help strengthen the balance sheet and support future investment. Research Solutions signals low single-digit transactions decline in FY 2027
- Positive Sentiment: August short interest declined 47.2% to 58,161 shares, equivalent to approximately 0.2% of shares outstanding and 3.5 days to cover. Reduced bearish positioning is a modestly supportive technical factor.
- Neutral Sentiment: Revenue of $12.08 million exceeded the $11.95 million analyst estimate, while return on equity was 27.45% and net margin was 9.28%. However, the revenue beat was accompanied by weaker-than-expected earnings.
- Neutral Sentiment: A separate September 10 report showed zero short interest, but this conflicts with the August data and appears to be a reporting or data-quality issue rather than a meaningful change in positioning.
- Negative Sentiment: Fourth-quarter earnings per share came in at $0.02-$0.03, below the $0.04 consensus estimate, and declined from $0.07 a year earlier. The earnings miss is likely the main reason for investor caution. Research Solutions Misses Q4 Earnings Estimates
- Negative Sentiment: Management expects a low-single-digit decline in transactions during fiscal 2027. Although profitability and cash flow are projected to improve, the anticipated volume decline raises concerns about near-term growth.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on the stock. Maxim Group reduced their target price on shares of Research Solutions from $5.00 to $4.00 and set a “buy” rating on the stock in a report on Friday, May 15th. Weiss Ratings reissued a “hold (c-)” rating on shares of Research Solutions in a research note on Wednesday, August 12th. Lake Street Capital lowered their price target on shares of Research Solutions from $5.00 to $4.00 and set a “buy” rating for the company in a research note on Monday, May 18th. Finally, Roth Capital restated a “buy” rating and set a $3.50 price target on shares of Research Solutions in a research report on Friday, May 15th. Three equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $3.83.
Read Our Latest Research Report on Research Solutions
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the company. Rothschild Wealth LLC bought a new stake in shares of Research Solutions in the 4th quarter worth approximately $1,049,000. Punch & Associates Investment Management Inc. increased its stake in shares of Research Solutions by 3.4% during the third quarter. Punch & Associates Investment Management Inc. now owns 2,499,310 shares of the company’s stock valued at $9,322,000 after buying an additional 81,210 shares during the period. Ashford Capital Management Inc. bought a new position in shares of Research Solutions during the third quarter valued at approximately $186,000. Topline Capital Management LLC bought a new position in shares of Research Solutions during the second quarter valued at approximately $125,000. Finally, Vanguard Group Inc. raised its holdings in shares of Research Solutions by 3.5% during the third quarter. Vanguard Group Inc. now owns 1,254,142 shares of the company’s stock valued at $4,678,000 after acquiring an additional 42,066 shares in the last quarter. 33.60% of the stock is owned by hedge funds and other institutional investors.
About Research Solutions
Research Solutions, Inc (NASDAQ:RSSS) is a provider of software and managed services that streamline access to and management of scientific, technical and medical research. The company’s flagship platform automates the acquisition, licensing and delivery of journal articles, conference proceedings and other pay-walled content, enabling institutions to reduce administrative overhead and control subscription costs.
Key offerings include self-service workflows for document requests, enterprise-grade managed services for high-volume users, and analytics tools that deliver detailed reporting on spend, usage patterns and supplier performance.
Read More
- Five stocks we like better than Research Solutions
- IBM and Lockheed Martin Turn a Swiss Defense Deal Into a Quantum Computing Bet
- AeroVironment’s Record Backlog and Earnings Beat Fuel Recovery Case
- Corning Just Locked In a Massive Verizon Fiber Deal as AI Infrastructure Expands
- 3 Under-$20 Stocks Tied to the Future of U.S. Energy and Materials
Receive News & Ratings for Research Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Research Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
